Ethamsylate
From Wikipedia, the free encyclopedia
 |
|
|
Ethamsylate
|
|
| Systematic (IUPAC) name | |
| 2,5-dihydroxybenzenesulfonic acid; N-ethylethanamine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C10H17NO5S |
| Mol. mass | 263.31068 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ethamsylate (dicynene) is a haemostatic drug that is believed to work by increasing capillary endothelial resistance and promoting platelet adhesion. It also inhibits biosynthesis and action of those prostaglandins which cause platelet disaggregation, vasodilation and increased capillary permeability.[citation needed]
[edit] References
 |
This article does not cite any references or sources. (October 2007) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
